Pirtobrutinib (LOXO-305), a highly selective and non-covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations. Pirtobrutinib causes regression of BTK-dependent lymphoma tumors in mouse xenograft models. Pirtobrutinib is al
Molecular Weight:
479.43
Purity:
99.88
CAS Number:
[2101700-15-4]
Formula:
C22H21F4N5O3
Target:
Btk
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted